预测COVID-19患者院内心脏骤停后的神经功能预后
该研究回顾性分析了GWTG-R COVID-19注册研究中2020年2月至2021年5月的心脏骤停复苏幸存者,共4125例COVID-19患者,其中484例(12%)以良好神经功能预后存活(出院时CPC≤2)。将非COVID-19患者中开发的逻辑回归、神经网络和梯度提升机模型应用于COVID-19队列,梯度提升机模型表现最佳,区分度显著优于CASPRI评分(c统计量0.75 vs 0.67,P<0.001);迁移学习改善了神经网络的校准,但区分度未超过梯度提升机。作者认为该模型可能为临床医生提供重要信息。
要点
- 在4125例COVID-19心脏骤停复苏幸存者中,484例(12%)以良好神经功能预后存活(出院CPC≤2)。
- 非COVID-19患者中开发的梯度提升机模型预测COVID-19患者神经功能预后最佳,c统计量0.75,显著优于CASPRI评分0.67(P<0.001)。
- 迁移学习改善了神经网络的校准,但其区分度未超过梯度提升机模型。
- 作者认为该梯度提升机模型具有高区分度和足够校准,可能为临床医生提供重要信息。
适用人群与场景
- GWTG-R COVID-19注册研究中2020年2月至2021年5月的心脏骤停复苏幸存者,共4125例COVID-19患者。
诊断标准与关键阈值
- 良好神经功能预后定义为出院时大脑功能分类(CPC)评分≤2。
研究设计与关键结果
- 研究类型:回顾性分析;数据来源:GWTG-R COVID-19注册研究;时间范围:2020年2月至2021年5月;样本量:4125例COVID-19心脏骤停复苏幸存者。
- 主要结局:484例(12%)以良好神经功能预后存活(出院CPC≤2)。
- 预测变量:骤停前和骤停期间变量。
- 模型比较:在非COVID-19患者中开发的梯度提升机模型表现最佳,c统计量0.75 vs CASPRI评分0.67,P<0.001。
- 迁移学习更新神经网络模型后校准改善,但区分度未超过梯度提升机模型。
证据类型、等级与局限
- 证据类型:回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在非COVID患者中开发的梯度提升机模型在COVID-19复苏幸存者中具有高区分度和足够校准,可能为临床医生提供这些患者的重要信息。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Machine learning models are more accurate than standard tools for predicting neurological outcomes in patients resuscitated after cardiac arrest. However, their accuracy in patients with Coronavirus Disease 2019 (COVID-19) is unknown. Therefore, we compared their performance in a cohort of cardiac arrest patients with COVID-19.
METHODS: We conducted a retrospective analysis of resuscitation survivors in the Get With The Guidelines®-Resuscitation (GWTG-R) COVID-19 registry between February 2020 and May 2021. The primary outcome was a favorable neurological outcome, indicated by a discharge Cerebral Performance Category score ≤ 2. Pre- and peri-arrest variables were used as predictors. We applied our published logistic regression, neural network, and gradient boosted machine models developed in patients without COVID-19 to the COVID-19 cohort. We also updated the neural network model using transfer learning. Performance was compared between models and the Cardiac Arrest Survival Post-Resuscitation In-Hospital (CASPRI) score.
RESULTS: Among the 4,125 patients with COVID-19 included in the analysis, 484 (12 %) patients survived with favorable neurological outcomes. The gradient boosted machine, trained on non-COVID-19 patients was the best performing model for predicting neurological outcomes in COVID-19 patients, significantly better than the CASPRI score (c-statistic: 0.75 vs 0.67, P < 0.001). While calibration improved for the neural network with transfer learning, it did not surpass the gradient boosted machine in terms of discrimination.
CONCLUSION: Our gradient boosted machine model developed in non-COVID patients had high discrimination and adequate calibration in COVID-19 resuscitation survivors and may provide clinicians with important information for these patients.
参考来源
- Mayampurath A, Bashiri F, Hagopian R, et al. Predicting neurological outcomes after in-hospital cardiac arrests for patients with Coronavirus Disease 2019. Resuscitation. 2022. PMID: 35868590. doi:10.1016/j.resuscitation.2022.07.018
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。